In a patient receiving intravenous heparin for stroke management who has sustained trauma causing Foley catheter injury, how should the bleeding be controlled?

Immediate Management of Foley Catheter Trauma Bleeding in a Heparinized Stroke Patient

Stop the heparin infusion immediately and administer protamine sulfate for urgent reversal, with the dose calculated based on the timing since heparin cessation, while simultaneously applying direct local pressure and balloon tamponade to control the bleeding site. 1, 2, 3, 4, 5

Step 1: Immediate Heparin Discontinuation and Reversal

Protamine sulfate is the Class I, Level B evidence-based reversal agent for heparin-associated bleeding 1, 3, 4. The most recent 2025 French guidelines 2 and 2022 AHA/ASA guidelines 5 strongly recommend:

• For intracranial hemorrhage or hemorrhagic shock: Immediate protamine administration is mandatory
• For severe bleeding (non-life-threatening): Consider protamine based on dose, route, and timing of heparin
• Dosing: Calculate based on time elapsed since heparin cessation (see FDA label 6)
  • If <30 minutes: 1 mg protamine per 100 units heparin
  • If 30-60 minutes: 0.5-0.75 mg per 100 units
  • If >2 hours: 0.25-0.375 mg per 100 units

The advantage of IV heparin over other anticoagulants is its rapid reversibility—protamine works within minutes 1, 7.

Step 2: Local Hemorrhage Control Measures

While reversing anticoagulation, simultaneously implement direct mechanical hemostasis 8:

Primary Local Measures:

• Direct manual pressure at the urethral/catheter site
• Foley balloon inflation (if catheter intact): Inflate balloon to 30-50 mL to provide tamponade effect 9
• Continuous bladder irrigation with cold saline through a three-way catheter to promote vasoconstriction and clot formation
• Packing of accessible bleeding sites if external

If Bleeding Persists:

• Consider urology consultation for cystoscopy and direct cauterization
• Interventional radiology for transarterial embolization if diffuse pelvic/urethral bleeding 10

Step 3: Supportive Resuscitation

Aggressive volume resuscitation with isotonic crystalloids (0.9% NaCl or Ringer's lactate) to maintain hemodynamic stability 8:

• Target hemoglobin ≥7 g/dL (≥8 g/dL if coronary artery disease present) 8
• Transfuse RBCs for symptomatic anemia or active bleeding
• Correct hypothermia and acidosis—both worsen coagulopathy 8
• Monitor serial hemoglobin, platelet count, and coagulation parameters 6

Step 4: Coagulation Monitoring

Check aPTT immediately to confirm heparin effect and guide protamine dosing 2, 6:

• Prolonged aPTT suggests on-therapy or above-therapy levels
• Measure anti-Factor Xa activity if available for precise quantification
• Recheck aPTT 5-10 minutes post-protamine to confirm reversal
• Monitor for rebound anticoagulation (heparin half-life ~60-90 minutes; protamine half-life ~7 minutes)

Step 5: Stroke Management Considerations

Critical decision point: Balance bleeding control against stroke progression risk 1, 7:

When to Resume Anticoagulation:

• Wait 24-48 hours minimum after achieving hemostasis 1, 7
• Reassess stroke type and bleeding risk:
  • If hemorrhagic transformation of ischemic stroke: May continue anticoagulation if asymptomatic and small 1, 7
  • If pure ischemic stroke with high embolic risk: Consider restarting heparin at lower intensity (aPTT 1.5× control) without bolus 1, 7

Avoid Heparin Boluses:

Never give bolus heparin when restarting—studies show bolus therapy significantly increases bleeding risk 1, 7, 11. Use continuous infusion only, starting at reduced rates.

Common Pitfalls to Avoid

1. Delaying protamine administration: Waiting for lab confirmation wastes critical time—treat based on clinical suspicion 2, 5
2. Over-reversal with protamine: Excess protamine has anticoagulant properties; calculate dose carefully 6
3. Premature heparin resumption: Restarting <24 hours risks rebleeding 1, 7
4. Using heparin boluses: Associated with increased hemorrhagic complications 1, 11
5. Inadequate local control: Pharmacologic reversal alone is insufficient—direct mechanical hemostasis is essential 8, 9

Special Considerations

• If bleeding continues despite protamine: Consider platelet transfusion (6-8 units) and cryoprecipitate, though evidence is limited to thrombolytic-associated bleeding 3, 4
• Monitor for heparin-induced thrombocytopenia (HIT): Check platelet count; if <100,000/mm³, evaluate for HIT and switch to alternative anticoagulant 6
• Renal function: Protamine dosing unaffected, but consider if patient has renal impairment affecting heparin clearance 6